AI주식인사이트AI Stock Insight
B

녹십자엠에스

142280KOSDAQ

66.3 / 100

Reference Date: 2026-09-08

Financial Score24.0 / 40
News Sentiment21.3 / 25
Momentum11.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health. Rose 11.6% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

Lotte MSD primarily operates in diagnostic reagents (54.1%), blood glucose management (14.4%), and hemodialysis solutions (31.1%), focusing on the development and sales of medical devices and diagnostic products. The company is advancing the development of multi-diagnostic platforms using AI and genomic analysis in the diagnostic reagents sector, while expanding its hemodialysis solution market through collaborations with global firms.

Number of Employees

131people

Average Salary

47.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
18.22Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR
1.59Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE
7.71Industry Average 8.002.5Point

Below industry avg

Debt Ratio
18.88Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20258.0 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲7.4% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲26.7% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 7.1% (improving, 3yr)

Detailed News Sentiment

1 totalPositive 1Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (17%, downtrend)

Current 3,080Won52-week high 6,23052-week low 2,395
1-month return5.0Point

1m +11.59% (rising)

Volume trend5.0Point

Volume increasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14